Molecular Biology Reports

, Volume 36, Issue 6, pp 1345–1352 | Cite as

Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA

  • Xiongtao Liu
  • Jian Yang
  • Fujun Shang
  • Changming Hong
  • Wangang Guo
  • Bing Wang
  • Qiangsun Zheng
Article
First Online:
Received:
Accepted:

Abstract

GIRK4 has been shown to be a subunit of IKACh, and the use of GIRK4 in human atrial myocytes to treat arrhythmia remains an important research pursuit. Adenovirus-delivered small hairpin RNA (shRNA) has been used to mediate gene knockdown in mouse cardiocytes, yet there is no information on the successful application of this technique in human cardiocytes. In the current study, we used a siRNA validation system to select the most efficient sequence for silencing GIRK4. To this end, adenovirus-delivered shRNA, which expresses this sequence, was used to silence GIRK4 expression in human atrial myocytes. Finally, the feasibility, challenges, and results of silencing GIRK4 expression were evaluated by RT-PCR, western blotting, and the voltage-clamp technique. The levels of mRNA and protein were depressed significantly in cells infected by adenovirus-delivered shRNA against GIRK4, approximately 86.3% and 51.1% lower than those cells infected by adenovirus-delivered nonsense shRNA, respectively. At the same time, IKACh densities were decreased 53% by adenovirus-delivered shRNA against GIRK4. In summary, adenovirus-delivered shRNA against GIRK4 mediated efficient GIRK4 knockdown in human atrial myocytes and decreased IKACh densities. As such, these data indicated that adenovirus-delivered shRNA against GIRK4 is a potential tool for treating arrhythmia.

Keywords

Human atrial myocytes RNA interference GIRK4 IKACh 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The authors thank Xiaojun Kang for assistance with the cell culture experiments described in this study. We are also grateful to Mei Xing for help with collecting specimens and Professor Zhipei Zhang and Lu Ding for assistance with molecular biology experiments.

References

  1. 1.
    Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811. doi: 10.1038/35888 PubMedCrossRefGoogle Scholar
  2. 2.
    Elbashir SM, Harborth J, Weber K, Tuschl T (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26:199–213. doi: 10.1016/S1046-2023(02)00023-3 PubMedCrossRefGoogle Scholar
  3. 3.
    Wickman K, Nemec J, Gendler SJ, Clapham DE (1998) Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20:103–114. doi: 10.1016/S0896-6273(00)80438-9 PubMedCrossRefGoogle Scholar
  4. 4.
    Kovoor P, Wickman K, Maguire CT, Pu W, Gehrmann J, Berul CI et al (2001) Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 37:2136–2143. doi: 10.1016/S0735-1097(01)01304-3 PubMedCrossRefGoogle Scholar
  5. 5.
    Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T et al (2005) The G protein-gated potassium current I (K, ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 112:3697–3706. doi: 10.1161/CIRCULATIONAHA.105.575332 PubMedCrossRefGoogle Scholar
  6. 6.
    Kurachi Y, Tung RT, Ito H, Nakajima T (1992) G protein activation of cardiac muscarinic K+ channels. Prog Neurobiol 39:229–246. doi: 10.1016/0301-0082(92)90017-9 PubMedCrossRefGoogle Scholar
  7. 7.
    Kubo Y, Reuveny E, Slesinger PA, Jan YN, Jan LY (1993) Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 364:802–806. doi: 10.1038/364802a0 PubMedCrossRefGoogle Scholar
  8. 8.
    Dascal N, Schreibmayer W, Lim NF, Wang W, Chavkin C, DiMagno L et al (1993) Atrial G protein-activated K+ channel: expression cloning and molecular properties. Proc Natl Acad Sci USA 90:10235–10239. doi: 10.1073/pnas.90.21.10235 PubMedCrossRefGoogle Scholar
  9. 9.
    Krapivinsky G, Gordon EA, Wickman K, Velimirovic B, Krapivinsky L, Clapham DE (1995) The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature 374:135–141. doi: 10.1038/374135a0 PubMedCrossRefGoogle Scholar
  10. 10.
    Hedin KE, Lim NF, Clapham DE (1996) Cloning of a Xenopus laevis inwardly rectifying K+ channel subunit that permits GIRK1 expression of IKACh currents in oocytes. Neuron 16:423–429. doi: 10.1016/S0896-6273(00)80060-4 PubMedCrossRefGoogle Scholar
  11. 11.
    Kennedy ME, Nemec J, Clapham DE (1996) Localization and interaction of epitope-tagged GIRK1 and CIR inward rectifier K+ channel subunits. Neuropharmacology 35:831–839. doi: 10.1016/0028-3908(96)00132-3 PubMedCrossRefGoogle Scholar
  12. 12.
    Ikeda SR, Jeong SW, Kammermeier PJ, Ruiz-Velasco V, King MM (1999) Heterologous expression of a green fluorescent protein-pertussis toxin S1 subunit fusion construct disrupts calcium channel modulation in rat superior cervical ganglion neurons. Neurosci Lett 271:163–166. doi: 10.1016/S0304-3940(99)00555-8 PubMedCrossRefGoogle Scholar
  13. 13.
    Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16:948–958. doi: 10.1101/gad.981002 PubMedCrossRefGoogle Scholar
  14. 14.
    Benardeau A, Hatem SN, Rucker-Martin C, Tessier S, Dinanian S, Samuel JL et al (1997) Primary culture of human atrial myocytes is associated with the appearance of structural and functional characteristics of immature myocardium. J Mol Cell Cardiol 29:1307–1320. doi: 10.1006/jmcc.1996.0366 PubMedCrossRefGoogle Scholar
  15. 15.
    Bird SD, Doevendans PA, van Rooijen MA, Brutel de la Riviere A, Hassink RJ, Passier R et al (2003) The human adult cardiomyocyte phenotype. Cardiovasc Res 58:423–434. doi: 10.1016/S0008-6363(03)00253-0 PubMedCrossRefGoogle Scholar
  16. 16.
    Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL (1999) A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 10:2667–2672. doi: 10.1089/10430349950016708 PubMedCrossRefGoogle Scholar
  17. 17.
    Kohout TA, O’Brian JJ, Gaa ST, Lederer WJ, Rogers TB (1996) Novel adenovirus component system that transfects cultured cardiac cells with high efficiency. Circ Res 78:971–977PubMedGoogle Scholar
  18. 18.
    Lipardi C, Wei Q, Paterson BM (2001) RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell 107:297–307. doi: 10.1016/S0092-8674(01)00537-2 PubMedCrossRefGoogle Scholar
  19. 19.
    Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, Timmons L et al (2001) On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107:465–476. doi: 10.1016/S0092-8674(01)00576-1 PubMedCrossRefGoogle Scholar
  20. 20.
    Kumar R, Conklin DS, Mittal V (2003) High-throughput selection of effective RNAi probes for gene silencing. Genome Res 13:2333–2340. doi: 10.1101/gr.1575003 PubMedCrossRefGoogle Scholar
  21. 21.
    McManus MT, Sharp PA (2002) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737–747. doi: 10.1038/nrg908 PubMedCrossRefGoogle Scholar
  22. 22.
    Matsuda S, Ichigotani Y, Okuda T, Irimura T, Nakatsugawa S, Hamaguchi M (2000) Molecular cloning and characterization of a novel human gene (HERNA) which encodes a putative RNA-helicase. Biochim Biophys Acta 1490:163–169PubMedGoogle Scholar
  23. 23.
    Sago N, Omi K, Tamura Y, Kunugi H, Toyo-oka T, Tokunaga K et al (2004) RNAi induction and activation in mammalian muscle cells where Dicer and eIF2C translation initiation factors are barely expressed. Biochem Biophys Res Commun 319:50–57. doi: 10.1016/j.bbrc.2004.04.151 PubMedCrossRefGoogle Scholar
  24. 24.
    Nicholson RH, Nicholson AW (2002) Molecular characterization of a mouse cDNA encoding Dicer, a ribonuclease III ortholog involved in RNA interference. Mamm Genome 13:67–73. doi: 10.1007/s00335-001-2119-6 PubMedCrossRefGoogle Scholar
  25. 25.
    Dobrev D, Graf E, Wettwer E, Himmel HM, Hala O, Doerfel C et al (2001) Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(KACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(KACh) and muscarinic receptor-mediated shortening of action potentials. Circulation 104:2551–2557. doi: 10.1161/hc4601.09946 PubMedCrossRefGoogle Scholar
  26. 26.
    Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498. doi: 10.1038/35078107 PubMedCrossRefGoogle Scholar
  27. 27.
    Bettahi I, Marker CL, Roman MI, Wickman K (2002) Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. J Biol Chem 277:48282–48288. doi: 10.1074/jbc.M209599200 PubMedCrossRefGoogle Scholar
  28. 28.
    Kennedy ME, Nemec J, Corey S, Wickman K, Clapham DE (1999) GIRK4 confers appropriate processing and cell surface localization to G-protein-gated potassium channels. J Biol Chem 274:2571–2582. doi: 10.1074/jbc.274.4.2571 PubMedCrossRefGoogle Scholar
  29. 29.
    Brundel BJ, Van Gelder IC, Henning RH, Tuinenburg AE, Wietses M, Grandjean JG et al (2001) Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol 37:926–932. doi: 10.1016/S0735-1097(00)01195-5 PubMedCrossRefGoogle Scholar
  30. 30.
    Jackson AL, Linsley PS (2004) Noise amidst the silence: off-target effects of siRNAs? Trends Genet 20:521–524. doi: 10.1016/j.tig.2004.08.006 PubMedCrossRefGoogle Scholar
  31. 31.
    Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R et al (2000) Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 102:2774–2780PubMedGoogle Scholar
  32. 32.
    Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G et al (2004) Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109:327–334. doi: 10.1161/01.CIR.0000112641.16340.C7 PubMedCrossRefGoogle Scholar
  33. 33.
    Hashimoto N, Yamashita T, Tsuruzoe N (2006) Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation. Pharmacol Res 54:136–141. doi: 10.1016/j.phrs.2006.03.021 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Xiongtao Liu
    • 1
  • Jian Yang
    • 2
  • Fujun Shang
    • 1
  • Changming Hong
    • 1
  • Wangang Guo
    • 1
  • Bing Wang
    • 1
  • Qiangsun Zheng
    • 1
  1. 1.Department of CardiologyAffiliated Tangdu Hospital of the Fourth Military Medical UniversityXi’anPeople’s Republic of China
  2. 2.Department of Cardiovascular SurgeryAffiliated Xijing Hospital of the Fourth Military Medical UniversityXi’anPeople’s Republic of China

Personalised recommendations